Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators -: A practical guide to patient treatment

被引:41
作者
Goldschlager, N
Epstein, A
Friedman, P
Gang, E
Krol, R
Olshansky, B
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham, AL 35294 USA
[4] Mayo Clin & Mayo Grad Sch Med, Dept Med, Rochester, MN 55901 USA
[5] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[6] Atlantic Hlth Syst Passaic, Cardiovasc Inst, Arrhythmia & Pacemaker Serv, Passaic, NJ USA
[7] Univ Iowa Hosp & Clin, Dept Med, Div Cardiol, Iowa City, IA 52242 USA
关键词
D O I
10.1001/archinte.161.5.649
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The potential for interaction between pacemakers and implantable cardioverter/ defibrillators (ICDs) and the medical and nonmedical environment, and between these devices and certain cardioactive drugs, has been recognized for years. Whereas a number of experimental and clinical studies have been performed to define some of these interactions, in man): instances data are sparse and anecdotal clinical experiences form the basis for decision making and recommendations. Nevertheless, given the proliferation of rhythm-management devices in use in the population today, practitioners may find a guide to management of these patients helpful. This management guideline is therefore offered not as an extensive, literature-based review, but as a framework on which to understand specific types of problems that may be encountered in the daily lives of patients who have such implanted devices.
引用
收藏
页码:649 / 655
页数:7
相关论文
共 21 条
[11]  
HUGHES HC, 1975, J THORAC CARDIOV SUR, V69, P743
[12]   Electromagnetic interference of pacemakers by mobile phones [J].
Irnich, W ;
Batz, L ;
Muller, R ;
Tobisch, R .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1996, 19 (10) :1431-1446
[13]  
KUBLER W, 1970, LANCET, V2, P67
[14]   FAILURE TO PACE FOLLOWING HIGH-DOSE ANTIARRHYTHMIC THERAPY - REVERSAL WITH ISOPROTERENOL [J].
LEVICK, CE ;
MIZGALA, HF ;
KERR, CR .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1984, 7 (02) :252-256
[15]   INTERACTIONS BETWEEN DRUGS AND DEVICES - EXPERIMENTAL AND CLINICAL-STUDIES [J].
MANZ, M ;
JUNG, W ;
LUDERITZ, B .
AMERICAN HEART JOURNAL, 1994, 127 (04) :978-984
[16]   EFFECT OF ANTIARRHYTHMIC DRUGS ON DEFIBRILLATION THRESHOLD - CASE-REPORT OF AN ADVERSE EFFECT OF MEXILETINE AND REVIEW OF THE LITERATURE [J].
MARINCHAK, RA ;
FRIEHLING, TD ;
KLINE, RA ;
STOHLER, J ;
KOWEY, PR .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1988, 11 (01) :7-12
[17]   Study of pacemaker and implantable cardioverter defibrillator triggering by electronic article surveillance devices (SPICED TEAS) [J].
McIvor, ME ;
Reddinger, J ;
Floden, E ;
Sheppard, RC ;
Johnson, D ;
Becker, GI ;
Mayotte, M .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1998, 21 (10) :1847-1861
[18]   Study of interactions between permanent pacemakers and electronic antitheft surveillance systems [J].
Mugica, J ;
Henry, L ;
Podeur, H .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (03) :333-337
[19]   CHANGES IN MYOCARDIAL THRESHOLD . PHYSIOLOGIC AND PHARMACOLOGIC FACTORS IN PATIENTS WITH IMPLANTED PACEMAKERS [J].
PRESTON, TA ;
FLETCHER, RD ;
LUCCHESI, BR ;
JUDGE, RD .
AMERICAN HEART JOURNAL, 1967, 74 (02) :235-&
[20]   EXIT BLOCK IN MYXEDEMA, TREATED EFFECTIVELY BY THYROID-HORMONE THERAPY [J].
SCHLESINGER, Z ;
ROSENBERG, T ;
STRYJER, D ;
GILBOA, Y .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1980, 3 (06) :737-739